Fanconi and Inappropriate Secretion of Antidiuretic Hormone Syndromes Secondary to Venlafaxine Therapy | Zendy

Hassane Izzedine | Zendy; Vincent LaunayVacher | Zendy; Magali Ciroldi | Zendy; L. Fardet | Zendy; Gilbert Deray | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fanconi and Inappropriate Secretion of Antidiuretic Hormone Syndromes Secondary to Venlafaxine Therapy

Author(s) -

Hassane Izzedine,

Vincent LaunayVacher,

Magali Ciroldi,

L. Fardet,

Gilbert Deray

Publication year - 2002

Publication title -

the nephron journals/nephron journals

Language(s) - English

Resource type - Journals

eISSN - 2235-3186

pISSN - 1660-8151

DOI - 10.1159/000065455

Subject(s) - medicine , endocrinology , anion gap , creatinine , urine osmolality , hypokalemia , hyponatremia , aldosterone , renal function , metabolic acidosis

Accessible online at: www.karger.com/journals/nef Venlafaxine, a 2-phenyl-2 (1-hydroxycycloalkyl) ethylamine derivate, is an inhibitor of both serotonin and norepinephrine re-uptake and was termed a ‘dual uptake inhibitor’ [1]. We report on a venlafaxine-treated patient who developed Fanconi’s syndrome (FS) and hyponatremia secondary to inappropriate antidiuretic hormone secretion syndrome (SIADH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research